These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2004-002752-34||A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF AGI 003 IN THE TREATMENT OF NON-CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME.||2005-06-06||due-trials|
|Not reported||2004-002762-38||A randomised, double-blind, placebo-controlled study of AGI 001 in the treatment of functional dyspepsia||2004-02-11||due-trials|
|Ongoing||2004-004230-14||A randomised, double-blind, placebo-controlled study of AGI 001 in the treatment of irritable bowel syndrome.||not-yet-due|
|Listed as ongoing, but also has a completion date||2005-000436-24||A randomised, double-blind, placebo-controlled study of AGI 006 in the treatment of functional dyspepsia.||2006-10-09||bad-data|
|Not reported||2007-003553-82||A Randomized, Double-blind, Placebo-controlled Study of AGI-003 (Arverapamil) in the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D)||2009-04-06||due-trials|
|Not reported||2007-003849-32||An Open-label, Roll-over Safety Study of AGI-003 (Arverapamil) in the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D)||2009-05-29||due-trials|
|Not reported||2007-004291-39||A randomised, multi-centre, double-blind, balanced, parallel group placebo-controlled study of AGI004 for the control of chemotherapy-induced diarrhoea.||2008-11-04||due-trials|